The Trinity College Dublin spinout is targeting a form of prostate gland enlargement with a device that could be installed in under 15 minutes.
Proverum Medical, an Ireland-based prostatic urethra therapy spinout from Trinity College Dublin, has closed a $4.2m seed round led by the spinout-focused University Bridge Fund, according to MedicalDesign & Outsourcing.
Angel syndicates Hban Medtech, Irrus Investments and Boole Investment all took part in the round, as did Xenium Capital.
Proverum Medical has developed a surgical implant to treat a prostate gland enlargement known as symptomatic benign prostatic hyperplasia, which mainly affects men over the age of 80 and can lead…
